British American Tobacco (BAT) is one of the world's largest cigarette suppliers, and with the decline of the tobacco industry, it has doubled its investments in new product categories like e-cigarettes.
The revenue of this London-based publicly traded company has grown in the past few months, despite the fact that the public in Europe and the United States tend to quit smoking.
The COVID-19 pandemic on both sides of the Atlantic has accelerated the shift towards quitting smoking. The bosses of major tobacco companies, known as BAT, now expect global tobacco sales to remain at around 2% for the entire year.
The company stated that they had initially believed that sales would continue to decline, but the resurgence of Covid-19 in emerging markets has resulted in an increase in tobacco sales.
The company stated that the revenue growth for British American Tobacco in the second quarter is between 2% and 4%, as they did not disclose a specific number prior to the upcoming financial update.
The CEO, Jack Bowles, stated that the company will continue investing in its new category as they seek to reduce operational losses.
We anticipate an increase in contributions from all new categories and regions by 2022. We have confidence in achieving our target of £5 billion in revenue and profit by 2025," he stated in a release.
In the US, industry sales are still facing pressure due to sustained macroeconomic factors and the post-Covid normalization of consumer patterns. To offset early signs of accelerated industry price cuts in the second half of the year, we recently initiated a commercial plan across specific brands, channels, and states.
Despite the increasing inflation rate in our supply chain, we anticipate a strong improvement in our adjusted operating profit margin. This will be achieved through robust pricing, the scale of our brand, and increasingly focused marketing investments. By the end of 2022, our three-year Quantum program is expected to save over £1.5 billion in costs annually.
2FIRSTS will continue to provide coverage on this topic, with further updates available on the 2FIRSTS APP. Scan the QR code below to download the app.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
